Comparative Outcomes after Haploidentical or Unrelated Donor Bone Marrow or Blood Stem Cell Transplantation in Adult Patients with Hematological Malignancies-Reference-Cited by-同舟云学术

Comparative Outcomes after Haploidentical or Unrelated Donor Bone Marrow or Blood Stem Cell Transplantation in Adult Patients with Hematological Malignancies

Published:2016-11 Issue:11 Volume:22 Page:2047-2055
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Baker Melissa,Wang Hongkun,Rowley Scott D.^ORCID,Cai Ling,Pecora Andrew L.,Skarbnik Alan^ORCID,Vesole David H.,Adler-Brecher Barbara,Kim Daniel,Donato Michele L.

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference39 articles.

1. Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse;Aversa;J Clin Oncol,2005

2. Unmanipulated HLA-mismatched/haploidentical blood and marrow hematopoietic stem cell transplantation;Huang;Biol Blood Marrow Transplant,2011

3. High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease;Luznik;Blood,2010

4. HLA-haploidentical bone marrow transplantation for hematologic malignancies using non-myeloablative conditioning and high dose post transplantation cyclophosphamide;Luznik;Biol Blood Marrow Transplant,2008

5. Prolongation of homograft survival in mice with single doses of cyclophosphamide;Berenbaum;Nature,1963

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic review and meta-analysis of HHV-6 and mortality after hematopoietic cell transplant;Bone Marrow Transplantation;2024-09-08

2. Prospects and Potential for Chimerism Analysis after Allogeneic Hematopoietic Stem Cell Transplantation;Cells;2024-06-06

3. Projected Impact of Omidubicel-onlv on Racial/Ethnic Disparities in Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) Outcomes in Hematologic Malignancies;Advances in Therapy;2024-03-01

4. Haploidentical vs Mismatched Unrelated Donor Transplants with Posttransplant Cyclophosphamide-based GVHD Prophylaxis;2024-02-16

5. Efficacy and safety of letermovir prophylaxis for cytomegalovirus infection after hematopoietic stem cell transplantation;Blood Science;2024-01